Literature DB >> 29994958

The Obese Colorectal Surgery Patient: Surgical Site Infection and Outcomes.

Tyler S Wahl1, Fenil C Patel, Lauren E Goss, Daniel I Chu, Jayleen Grams, Melanie S Morris.   

Abstract

BACKGROUND: Obese patients undergoing colorectal surgery are at increased risk for adverse outcomes. It remains unclear whether these risks can be further defined with more discriminatory stratifications of obesity.
OBJECTIVE: The purpose of this study was to understand the association between BMI and 30-day postoperative outcomes, including surgical site infection, among patients undergoing colorectal surgery.
DESIGN: This was a retrospective cohort study. SETTINGS: The 2011-2013 American College of Surgeons National Surgical Quality Improvement Program database was used. PATIENTS: Patients included those undergoing elective colorectal surgery in 2011-2013 who were assessed by the American College of Surgeons National Surgical Quality Improvement Program. MAIN OUTCOME MEASURES: BMI was categorized into World Health Organization categories. Primary outcome was 30-day postoperative surgical site infection. Secondary outcomes included all American College of Surgeons National Surgical Quality Improvement Program-assessed 30-day postoperative complications.
RESULTS: Our cohort included 74,891 patients with 4.4% underweight (BMI <18.5), 29.0% normal weight (BMI 18.5-24.9), 33.0% overweight (BMI 25.0-29.9), 19.8% obesity class I (BMI 30.0-34.9), 8.4% obesity class II (BMI 35.0-39.9), and 5.5% obesity class III (BMI ≥40.0). Compared with normal-weight patients, obese patients experienced incremental odds of surgical site infection from class I to class III (I: OR = 1.5 (95% CI, 1.4-1.6); II: OR = 1.9 (95% CI, 1.7-2.0); III: OR = 2.1 (95% CI, 1.9-2.3)). Obesity class III patients were most likely to experience wound disruption, sepsis, respiratory or renal complication, and urinary tract infection. Mortality was highest among underweight patients (OR = 1.3 (95% CI, 1.0-1.8)) and lowest among overweight (OR = 0.8 (95% CI, 0.6-0.9)) and obesity class I patients (OR = 0.8 (95% CI, 0.6-1.0)). LIMITATIONS: Retrospective analysis of American College of Surgeons National Surgical Quality Improvement Program hospitals may not represent patients outside of the American College of Surgeons National Surgical Quality Improvement Program and cannot assign causation or account for interventions to improve surgical outcomes.
CONCLUSIONS: Patients with increasing BMI showed an incremental and independent risk for adverse 30-day postoperative outcomes, especially surgical site infections. Strategies to address obesity preoperatively should be considered to improve surgical outcomes among this population. See Video Abstract at http://links.lww.com/DCR/A607.

Entities:  

Mesh:

Year:  2018        PMID: 29994958      PMCID: PMC6609287          DOI: 10.1097/DCR.0000000000001085

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  11 in total

Review 1.  Association between body mass index and urinary tract infection: a systematic review and meta-analysis of observational cohort studies.

Authors:  Habeeb Alhabeeb; Saeed Baradwan; Hamed Kord-Varkaneh; Shing Cheng Tan; Teck Yew Low; Osama Alomar; Hany Salem; Ismail Abdulrahman Al-Badawi; Ahmed Abu-Zaid
Journal:  Eat Weight Disord       Date:  2021-01-09       Impact factor: 4.652

2.  Posterior mesorectal thickness as a predictor of increased operative time in rectal cancer surgery: a retrospective cohort study.

Authors:  Tyler McKechnie; Karim Ramji; Colin Kruse; Hussein Jaffer; Ryan Rebello; Nalin Amin; Aristithes G Doumouras; Dennis Hong; Cagla Eskicioglu
Journal:  Surg Endosc       Date:  2021-08-11       Impact factor: 4.584

Review 3.  Mortality risk in patients with underweight or obesity with peripheral artery disease: a meta-analysis including 5,735,578 individuals.

Authors:  Donna Shu-Han Lin; Hao-Yun Lo; An-Li Yu; Jen-Kuang Lee; Kuo-Liong Chien
Journal:  Int J Obes (Lond)       Date:  2022-05-16       Impact factor: 5.551

Review 4.  Systematic review and meta-analysis: association between obesity/overweight and surgical complications in IBD.

Authors:  Ke Jiang; Bangsheng Chen; Dandi Lou; Mengting Zhang; Yetan Shi; Wei Dai; Jingyi Shen; Bin Zhou; Jinxing Hu
Journal:  Int J Colorectal Dis       Date:  2022-05-31       Impact factor: 2.796

5.  Defining Microbiome Readiness for Surgery: Dietary Prehabilitation and Stool Biomarkers as Predictive Tools to Improve Outcome.

Authors:  Robert Keskey; Emily Papazian; Adam Lam; Tiffany Toni; Sanjiv Hyoju; Renee Thewissen; Alexander Zaborin; Olga Zaborina; John C Alverdy
Journal:  Ann Surg       Date:  2020-11-04       Impact factor: 13.787

Review 6.  Excessive Body Weight and Diverticular Disease.

Authors:  Stephan K Böhm
Journal:  Visc Med       Date:  2021-09-15

Review 7.  Obese patients and robotic colorectal surgery: systematic review and meta-analysis.

Authors:  Y Suwa; M Joshi; L Poynter; I Endo; H Ashrafian; A Darzi
Journal:  BJS Open       Date:  2020-09-21

Review 8.  Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition.

Authors:  Gabriella Pugliese; Alessia Liccardi; Chiara Graziadio; Luigi Barrea; Giovanna Muscogiuri; Annamaria Colao
Journal:  Int J Obes (Lond)       Date:  2022-01-21       Impact factor: 5.095

9.  Associations Between Social Risk Factors and Surgical Site Infections After Colectomy and Abdominal Hysterectomy.

Authors:  Andrew C Qi; Kate Peacock; Alina A Luke; Abigail Barker; Margaret A Olsen; Karen E Joynt Maddox
Journal:  JAMA Netw Open       Date:  2019-10-02

10.  Mice Fed an Obesogenic Western Diet, Administered Antibiotics, and Subjected to a Sterile Surgical Procedure Develop Lethal Septicemia with Multidrug-Resistant Pathobionts.

Authors:  Olga Zaborina; John C Alverdy; Sanjiv K Hyoju; Alexander Zaborin; Robert Keskey; Anukriti Sharma; Wyatt Arnold; Fons van den Berg; Sangman M Kim; Neil Gottel; Cindy Bethel; Angella Charnot-Katsikas; Peng Jianxin; Carleen Adriaansens; Emily Papazian; Jack A Gilbert
Journal:  mBio       Date:  2019-07-30       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.